DNA methylation and histone H3-K9 modifications contribute to MUC17 expression.

MUC17 glycoprotein is a membrane-associated mucin that is mainly expressed in the digestive tract. It has been suggested that MUC17 expression is correlated with the malignancy potential of pancreatic ductal adenocarcinomas (PDACs). In the present study, we provided the first report of the MUC17 gene expression through epigenetic regulation such as promoter methylation, histone modification and microRNA (miRNA) expression. Near the transcriptional start site, the DNA methylation level of MUC17-negative cancer cell lines (e.g. PANC1) was high, whereas that of MUC17-positive cells (e.g. AsPC-1) was low. Histone H3-K9 (H3-K9) modification status was also closely related to MUC17 expression. Our results indicate that DNA methylation and histone H3-K9 modification in the 5' flanking region play a critical role in MUC17 expression. Furthermore, the hypomethylation status was observed in patients with PDAC. This indicates that the hypomethylation status in the MUC17 promoter could be a novel epigenetic marker for the diagnosis of PDAC. In addition, the result of miRNA microarray analysis showed that five potential miRNA candidates existed. It is also possible that the MUC17 might be post-transcriptionally regulated by miRNA targeting to the 3'-untranslated region of its mRNA. These understandings of the epigenetic changes of MUC17 may be of importance for the diagnosis of carcinogenic risk and the prediction of outcomes for cancer patients.

[1]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Goto,et al.  MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer , 2006, International journal of cancer.

[3]  Y. S. Kim,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors , 1993, Cancer.

[4]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[5]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[6]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[7]  M. Caligiuri,et al.  MicroRNA expression in cytogenetically normal acute myeloid leukemia. , 2008, The New England journal of medicine.

[8]  Bradley S. Turner,et al.  Viscous fingering of HCI through gastric mucin , 1992, Nature.

[9]  S. Ho,et al.  Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. , 2006, Gastroenterology.

[10]  V. Korolik,et al.  Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.

[11]  M. Goto,et al.  MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells. , 2008, Cancer research.

[12]  D. Gotley,et al.  Two novel mucin genes down-regulated in colorectal cancer identified by differential display. , 1999, Cancer research.

[13]  M. Goto,et al.  Significance of mucin expression in pancreatobiliary neoplasms , 2010, Journal of hepato-biliary-pancreatic sciences.

[14]  B. Longenecker,et al.  Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. , 1998, Cancer research.

[15]  S. Crawley,et al.  MUC17, a novel membrane-tethered mucin. , 2002, Biochemical and biophysical research communications.

[16]  M. Goto,et al.  Promoter CpG methylation in cancer cells contributes to the regulation of MUC4 , 2009, British Journal of Cancer.

[17]  John K Field,et al.  Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Y. Miki,et al.  Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome‐wide expression profiling , 2010, Cancer science.

[19]  C. A. Carraway,et al.  Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways , 2002, Oncogene.

[20]  S. Yonezawa,et al.  Promoter hypomethylation contributes to the expression of MUC3A in cancer cells. , 2010, Biochemical and biophysical research communications.

[21]  S. Yonezawa,et al.  Expression of mucin antigens in human cancers and its relationship with malignancy potential , 1997, Pathology international.

[22]  Peter A. Jones,et al.  Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. , 2002, Cancer research.

[23]  J. Hedenbro,et al.  Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins. , 2004, The Biochemical journal.

[24]  M. Goto,et al.  Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior , 2008, Proteomics.

[25]  M. Esteller,et al.  How epigenetics can explain human metastasis: A new role for microRNAs , 2009 .

[26]  S. Batra,et al.  Characterization of Human Mucin MUC17 , 2006, Journal of Biological Chemistry.

[27]  M. Goto,et al.  Expression of MUC5AC, an early marker of pancreatobiliary cancer, is regulated by DNA methylation in the distal promoter region in cancer cells , 2010, Journal of hepato-biliary-pancreatic sciences.

[28]  Mikiko C. Siomi,et al.  The Discovery of Rna Interference (rnai) Biogenesis of Small Rnas on the Road to Reading the Rna-interference Code Insight Review , 2022 .

[29]  J. Issa,et al.  Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal Cancer , 2003, Molecular and Cellular Biology.

[30]  S. Crawley,et al.  Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. , 2002, Gastroenterology.

[31]  Julian C. Knight,et al.  Regulatory polymorphisms underlying complex disease traits , 2005, Journal of Molecular Medicine.

[32]  Gerd Schmitz,et al.  Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease , 2006, Journal of Molecular Medicine.

[33]  J. Taylor‐Papadimitriou,et al.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T‐cell migration , 2003, Immunology.

[34]  M. Hollingsworth,et al.  MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. , 1997, Human pathology.

[35]  Jaehong Park,et al.  A Minimal Fragment of MUC1 Mediates Growth of Cancer Cells , 2008, PloS one.

[36]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.